Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

GPR132 Receptor Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Threoine339/Serine341 phosphorylation of GPR132
pT339/pS341-GPR132 (phospho-GPR132 Antibody)
Threonine339/Serine341 (T339/S341) is major phosphorylation site of human GPR132 receptor. The pT339/pS341-GPR132 antibody detects phosphorylation in response to agonists. T339/S341 phosphorylation is likely to be involved in efficient...
$ 350.00 *
NEW
Agonist-induced Threonine344/Serine349 phosphorylation of GPR132
pT344/pS349-GPR132 (phospho-GPR132 Antibody)
Threonine344/Serine349 (T344/S349) is major phosphorylation site of human GPR132 receptor. The pT344/pS349-GPR132 antibody detects phosphorylation in response to agonists. T344/S349 phosphorylation is likely to be involved in efficient...
$ 350.00 *
NEW
Agonist-induced Threonine358/Serine360 phosphorylation of GPR132
pT358/pS360-GPR132 (phospho-GPR132 Antibody)
Threonine358/Serine360 (T358/S360) is major phosphorylation site of human GPR132 receptor. The pT358/pS360-GPR132 antibody detects phosphorylation in response to agonists. T358/S360 phosphorylation is likely to be involved in efficient...
$ 350.00 *

GPR132 has been reported to be activated by oxidized free fatty acids produced by oxidation and subsequent hydrolysis of phosphatidylcholine or cholesteryl linoleate or lysophosphatidylserine. GPR132 is also thought to function as proton-sensing receptors detecting acidic pH. GPR132 is most likely a receptor for oxidized free fatty acids derived from linoleic and arachidonic acids such as 9-hydroxyoctadecadienoic acid (9-HODE). GPR132 is regulated by phosphorylation of carboxyl-terminal threonine339/serine341 (pT339/pS341-GPR132), threonine344/serine349 (pT344/pS349-GPR132) and threonine358/serine360 (pT344/pS360-GPR132). This nomenclature refers to the human GPR132 receptor. For more information on GPR132 pharmacology please refer to the IUPHAR database. For further reading refer to:

Alexander SP, Battey J, Benson HE, Benya RV, Bonner TI, Davenport AP, Dhanachandra Singh K, Eguchi S, Harmar A, Holliday N, Jensen RT, Karnik S, Kostenis E, Liew WC, Monaghan AE, Mpamhanga C, Neubig R, Pawson AJ, Pin JP, Sharman JL, Spedding M, Spindel E, Stoddart L, Storjohann L, Thomas WG, Tirupula K, Vanderheyden P. Class A Orphans in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1). Available from: https://doi.org/10.2218/gtopdb/F16/2023.1.

 

GPR132 has been reported to be activated by oxidized free fatty acids produced by oxidation and subsequent hydrolysis of phosphatidylcholine or cholesteryl linoleate or lysophosphatidylserine.... read more »
Close window
GPR132 Receptor Antibodies

GPR132 has been reported to be activated by oxidized free fatty acids produced by oxidation and subsequent hydrolysis of phosphatidylcholine or cholesteryl linoleate or lysophosphatidylserine. GPR132 is also thought to function as proton-sensing receptors detecting acidic pH. GPR132 is most likely a receptor for oxidized free fatty acids derived from linoleic and arachidonic acids such as 9-hydroxyoctadecadienoic acid (9-HODE). GPR132 is regulated by phosphorylation of carboxyl-terminal threonine339/serine341 (pT339/pS341-GPR132), threonine344/serine349 (pT344/pS349-GPR132) and threonine358/serine360 (pT344/pS360-GPR132). This nomenclature refers to the human GPR132 receptor. For more information on GPR132 pharmacology please refer to the IUPHAR database. For further reading refer to:

Alexander SP, Battey J, Benson HE, Benya RV, Bonner TI, Davenport AP, Dhanachandra Singh K, Eguchi S, Harmar A, Holliday N, Jensen RT, Karnik S, Kostenis E, Liew WC, Monaghan AE, Mpamhanga C, Neubig R, Pawson AJ, Pin JP, Sharman JL, Spedding M, Spindel E, Stoddart L, Storjohann L, Thomas WG, Tirupula K, Vanderheyden P. Class A Orphans in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1). Available from: https://doi.org/10.2218/gtopdb/F16/2023.1.

 

Recently viewed